Brown & Brown, Inc. Announces the Asset Acquisition of herronpalmer
Aug 21, 2017 11:00 am UTC| Business
DAYTONA BEACH, Fla., Aug. 21, 2017 -- J. Scott Penny, Chief Acquisitions Officer of Brown Brown, Inc. (NYSE:BRO), and Felicia Palmer and Tony Herron, the founders of herronpalmer, LLC (“herronpalmer”), today announced...
Hill International Announces Profit Improvement Plan and Reiterates Full Year 2017 Revenue Guidance
Aug 21, 2017 10:45 am UTC| Business
PHILADELPHIA, Aug. 21, 2017 -- Hill International (NYSE:HIL), the global leader in managing construction risk, today announced that the Company and its Board of Directors have undertaken several initiatives to improve...
Aug 21, 2017 10:30 am UTC| Business
IRVINE, Calif., Aug. 21, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage,...
Michael Ertel Joins Safeware as New Business Development Manager
Aug 21, 2017 10:30 am UTC| Business
Dublin, Ohio, Aug. 21, 2017 -- Safeware, a leading provider of product protection and extended warranty solutions, is pleased to announce the addition of Michael (Mike) Ertel to its business development and sales team....
Cagan McAfee Capital Partners teams with Myles Sherman to Acquire Minimally Invasive Devices
Aug 21, 2017 10:11 am UTC| Business
CUPERTINO, Calif., Aug. 21, 2017 -- Cagan McAfee Capital Partners and seasoned investor/operator, Myles Sherman of Austin, TX, have teamed up to acquire Minimally Invasive Devices (MID). Laird Cagan, will be...
Nidec to Acquire SV Probe Pte. Ltd., a Probe Card Manufacturer
Aug 21, 2017 10:04 am UTC| Business
KYOTO, Japan, Aug. 21, 2017 -- Nidec Corporation (TSE:6594) (OTC US:NJDCY) (the “Company” or “Nidec”) today announced that the Company has agreed to acquire 100% equity shares of SV Probe Pte. Ltd. (“SV Probe”), a probe...
CytoDyn Provides Update on PRO 140 Pivotal Combination Therapy Trial in Patients with HIV
Aug 21, 2017 10:00 am UTC| Business
VANCOUVER, Washington, Aug. 21, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that...